The World Ovarian Cancer Coalition announced that a groundbreaking international study, "Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Woman Studytm LMIC): a ...

A team of 30 doctors helped Suze Lopez , 41, deliver her son — and remove the tumor — in a "profound" medical marvel ...

A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big ...

The addition of the immune checkpoint inhibitor Tecentriq (atezolizumab) to neoadjuvant chemotherapy and as a single agent ...

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

Sperm donation is common in today’s world. In fact, it is preferred by many couples and individuals who are struggling with ...

Immatics (IMTX) announced updated Phase 1a dose escalation data from its second-generation PRAME cell therapy, IMA203CD8, in heavily pre-treated ...

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across ...

About 55 Penn Middle School students and staff packed and donated tote bags for local cancer patients in honor of late ...

Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...

Gynecological malignancies constitute a rather significant health burden, worldwide, with an incidence rate of approximately 30.4 per 100,000 population.

Aromatase inhibitors demonstrated superior disease-free survival and time to distant recurrence compared to SERMs in HR+/HER2+ early breast cancer. The benefits of aromatase inhibitors were consistent ...